Publications 2010

Anderson KE, Gehl CR, Marder KS, Beglinger LJ, Paulsen JS; Huntington’s Study Group.Comorbidities of obsessive and compulsive symptoms in Huntington’s disease.J Nerv Ment Dis, 2010 May,198(5):334-8.

Beglinger LJ, O’Rourke JJ, Wang C, Langbehn DR, Duff K, Paulsen JS; Huntington Study Group Investigators. Earliest functional declines in Huntington disease. Psychiatry Res. 2010 Jul 30; 178(2):414-8. Epub, 2010, May 15.

Brown RG, Lacomblez L, Landwehrmeyer BG, Bak T, Uttner I, Dubois B, Agid Y, Ludolph A, Bensimon G, Payan C, Leigh NP; NNIPPS STUDY GROUP. Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. Brain, 2010, 133:2382-93.

Ciampi de Andrade D, Gurruchaga J-M; Jarraya B, Goujon B, Beaugendre Y, Lepetit H Tani N, Mandat T, Kirov K, Fénelon G, Brugières P, Palfi S. Paroxysmal positive symptoms caused by hardware malfunctioning in deep brain stimulation. Brain Stimulation, 2010, 3: 61-62.

De Diego-Balaguer R., Rodriguez-Fornells, A. Contributions to the functional neuroanatomy of morphosyntactic processing in L2. Language Learning, 2010, 60 (1), 231-259

De Diego-Balaguer, R. López-Barroso, D. Cognitive and Neural Mechanisms Sustaining Rule Learning from Speech. Language Learning. 2010,60(s2): 151-187

Fénelon G, Alves G. Epidemiology of psychosis in Parkinson’s disease. J Neurol Sci. 2010 Feb 15;289(1-2):12-7. Epub 2009, Sep 8.

Fénelon G, Cesaro P. Troubles psychiques et comportementaux de la maladie de Parkinson. Bull Acad Nat Med, 2010, 194: 1305-1319.

Fénelon G, Soulas T, Zenasni F, Cleret de Langavant L. The changing profile of Parkinson’s disease-assocuated psychosis: a cross-sectional study based on the new NINDS-NIMH criteria. Mov Disord, 2010; 25: 763-766.

Jarraya B, Brugières B, Tani, N, Hodel J, Grandjacques B, Fénelon G, Decq P, and Palfi S. Disruption of Cigarette Smoking Addiction After Posterior Cingulate Damage. J Neurosurg, 2010,113:1219-1221

Macoir J, Fossard M, Nespoulous J-L, Demonet J-F, Bachoud-Lévi A-C. The Application of Rules in Morphology, Syntax and Number Processing: A Case of Selective Deficit of Procedural or Executive Mechanisms? Neurocase, 2010, May 5:1-19.

Orth M; European Huntington’s Disease Network, Handley OJ, Schwenke C, Dunnett S-B, Craufurd D, Ho A, Wild EJ, Tabrizi SJ. Observing Huntington’s Disease: the European Huntington’s Disease Network’s REGISTRY. PLoS Curr 2010, Sep 28;2. pii: RRN1184

Paris A, Brandt C, Cornu C, Maison P, Thalamas C, Cracowski JL. Informed consent document improvement does not increase patients’ comprehension in biomedical research. Br J Clin Pharmacol, 2010, Mar; 69(3):231-7.

Radue EW, Stuart WH, Calabresi P-A, Confavreux C, Galetta SL, Rudick R-A, Lublin F-D, Weinstock-Guttman B, Wynn D-R, Fisher E, Papadopoulou A, Lynn F, Panzara MA, Sandrock AW; SENTINEL Investigators. Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis. J Neurol Sci. 2010 May 15; 292(1-2):28-35. Epub, 2010, Mar 16.

Rascol O, Azulay J-P, Blin O, Bonnet AM, Brefel-Courbon C, Cesaro P, Damier P, Debilly B, Durif F, Galitzky M, Grouin JM, Pennaforte S, Villafane G, Yaici S, Agid Y. Orodispersible sublingual piribedil to abort OFF episodes: a single dose placebo-controlled, randomized, double-blind, cross-over study. Mov Disord, 2010, Feb 15;25(3):368-76.PMID: 20063435

Saleh N, Moutereau S, Azulay J-P, VernyC, Simonin C, Tranchant C, El Hawajri, N, Bachoud-Lévi A-C*, Maison P* and the Huntington French Speaking Group. High Insulin-Like Growth Factor I is associated with Cognitive Decline in Huntington’s Disease. Neurology, 2010, Jul 6; 75(1):57-63

Van Meerbeeck P, Fénelon G, Ahdab R, Lefaucheur J-P. Electrophysiological assessment of paraneoplastic limb myorhythmia. Clin Neurophysiol, 2010,121:2180-2183